stockrow
Friday 6 November 2026
Export ISPC’s income statement to Excel — free account
iSpecimen Inc.
ISPC Healthcare Diagnostics & Research
iSpecimen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 79.2% from fiscal 2024.
- Revenue
- −78.7%
- EPS
- +94.2%
- Free cash flow
- −257.7%
Quarter to June 2026, against a year earlier
0.80
0.04
−4.76%
Follow ISPC
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 3 | 4 | 2 | 7 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(14.80) | (14.35) | (6.34) | (1.24) | 2.71 | — | — | — | — |
P/S ratio |
1.04 | 0.32 | 0.48 | 1.20 | 3.03 | 0.73 | 0.73 | 0.73 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(33.49) | (35.16) | (14.39) | (0.12) | 6.28 | (38.33) | (47.90) | (42.51) | — |
P/Operating CF |
(2.20) | (0.84) | 13.76 | (60.40) | (25.57) | (54.39) | (54.39) | (54.39) | — |
Beneish M-Score |
10.08 | (5.11) | (4.09) | (2.95) | (1.52) | (5.03) | (4.32) | — | — |
P/B ratio |
0.65 | 0.91 | 0.49 | 0.62 | 1.13 | 0.00 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.97 | 1.16 | 0.54 | 0.79 | 1.25 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
(1.17) | 0.40 | 0.24 | (0.02) | 0.85 | 1.87 | 1.87 | 1.87 | — |
EV/EBITDA |
0.31 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
0.53 | (0.45) | (0.41) | 0.03 | (0.88) | (42.69) | (42.69) | (42.69) | — |
EV/FCF |
0.30 | (0.34) | (0.18) | 0.01 | (0.74) | (28.11) | (28.11) | (28.11) | — |
Quick Ratio |
1.11 | 0.58 | 1.31 | 4.53 | 13.02 | 0.14 | 0.09 | 0.19 | — |
Current Ratio |
1.12 | 0.62 | 1.36 | 4.60 | 13.15 | 0.16 | 0.10 | 0.20 | — |
Net Debt/EBITDA |
0.95 | 0.18 | 0.55 | 1.72 | 6.00 | 0.36 | (4.13) | (5.89) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 9.58% | 2.88% | 265.10% | 448.54% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.11 | (0.01) | (0.97) | (0.98) | — |
Asset Turnover |
0.20 | 0.74 | 0.49 | 0.34 | 0.53 | 1.57 | 1.04 | 2.17 | — |
Operating CF/Net income |
0.40 | 0.66 | 0.52 | 0.57 | 1.19 | 0.06 | 0.57 | 0.50 | — |
Capex/Depreciation |
(0.58) | (0.30) | (2.24) | (4.81) | (1.11) | (2.29) | (2.46) | 0.00 | — |
Interest Coverage |
(4,725.21) | (73.23) | (698.09) | (42.62) | (2.82) | (1.15) | (2.25) | (5.52) | — |
| (327.78%) | (191.51%) | (73.87%) | (40.90%) | (713.06%) | 18.61% | 22.98% | 25.99% | — | |
| (111.09%) | (99.31%) | (54.90%) | (33.96%) | (42.75%) | (89.25%) | (114.47%) | (264.41%) | — | |
ROIC |
0.00% | (555.29%) | (147.42%) | (127.31%) | (67.64%) | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(1,400.57%) | 598.30% | (478.94%) | (65.59%) | (29.41%) | 25.03% | 33.62% | 60.47% | — |
Average Days of Receivables |
9.14 | 56.75 | 108.12 | 142.69 | 160.04 | 105.19 | 118.25 | 85.20 | — |
Research and Development Expense of Revenue |
12.80% | 5.79% | 10.38% | 7.70% | 5.15% | 6.08% | 18.44% | 42.86% | — |
Selling, General and Administrative Expense of Revenue |
299.00% | 118.53% | 99.63% | 99.77% | 72.17% | 51.11% | 77.93% | 79.76% | — |
Intangible Assets out of Total Assets |
0.10 | 0.08 | 0.06 | 0.18 | 0.08 | 0.42 | 0.55 | 0.36 | 0.00 |
Share Based Compensation of Revenue |
1.10% | 2.69% | 4.63% | 6.52% | 5.59% | 1.14% | 8.38% | 0.00% | — |
Graham Net Nets |
0.25 | (0.82) | 0.46 | 1.23 | 0.80 | 0.45 | 0.45 | 0.45 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 336.95 | 0.00 | 0.00 | — |
Earnings Yield |
(867.40%) | (664.36%) | (234.24%) | (82.27%) | (26.79%) | (80.45%) | (80.45%) | (80.45%) | — |
Free Cash Flow Yield |
(370.41%) | (369.08%) | (279.84%) | (95.72%) | (37.77%) | (9.17%) | (9.17%) | (9.17%) | — |
Revenue per Share |
16.76 | 521.97 | 878.60 | 937.14 | 2,062.09 | 6,820.08 | 3,582.00 | 0.67 | — |
Operating CF per Share |
(36.84) | (464.25) | (513.95) | (524.12) | (1,975.63) | (240.33) | (2,233.25) | (0.41) | — |
Capex per Share |
(8.69) | (38.47) | (419.88) | (555.58) | (383.94) | (1,837.33) | (2,435.25) | 0.00 | — |
Free Cash Flow per Share |
(45.54) | (502.72) | (933.82) | (1,079.69) | (2,359.57) | (2,077.67) | (4,668.50) | (0.41) | — |
Cash per Share |
59.78 | 105.53 | 442.97 | 1,379.16 | 5,136.85 | 579.92 | 44.92 | 0.17 | — |
Shareholders Equity per Share |
26.83 | 186.01 | 862.04 | 1,829.66 | 5,516.96 | (13,420.75) | (9,621.42) | (2.81) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | — |
Book value per Share |
26.83 | 186.01 | 862.04 | 1,829.66 | 5,516.96 | (13,420.75) | (9,621.42) | (2.81) | — |
Free Cash Flow |
(5.24) | (8.95) | (10.55) | (11.98) | (12.74) | (2.49) | (5.60) | (2.69) | — |
Working Capital |
0.72 | (2.18) | 2.19 | 15.39 | 30.44 | (18.66) | (14.18) | (8.99) | — |
Capital Expenditures |
(1.00) | (0.68) | (4.74) | (6.17) | (2.07) | (2.20) | (2.92) | (1.03) | — |
Net Current Asset Value |
0.51 | (2.45) | 2.16 | 15.37 | 27.02 | (18.84) | (14.18) | (20.16) | — |
EV/EBIT |
0.25 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.52 | 0.07 | 0.48 | 0.59 | 0.19 | 0.27 | 0.68 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
67.88 | 24.51 | 16.55 | 5.68 | 57.16 | 12.74 | 9.90 | 3.15 | — |
Cash ROIC |
(52.57%) | (172.44%) | (71.56%) | (33.65%) | (20.90%) | 16.37% | 1,757.83% | (317.45%) | — |
Accounts Receivable Turnover |
2.58 | 4.24 | 2.83 | 2.32 | 3.08 | 4.36 | 3.55 | 3.63 | — |
Accounts Payable Turnover |
0.40 | 1.31 | 1.51 | 2.89 | 4.00 | 2.83 | 2.97 | 3.29 | — |
Inventory Turnover |
0.00 | 106.05 | 0.00 | 0.00 | 0.00 | 0.00 | 41.64 | 46.23 | — |
Average Days of Payables |
1,027.53 | 288.93 | 297.24 | 188.68 | 57.90 | 182.46 | 126.56 | 107.67 | — |
Days of Inventory on Hand |
0.00 | 3.10 | 0.00 | 0.00 | 0.00 | 0.00 | 9.42 | 7.31 | — |
Average Receivables |
0.75 | 2.19 | 3.50 | 4.47 | 3.62 | 1.88 | 1.21 | 1.21 | — |
Average Payables |
4.78 | 4.06 | 3.19 | 1.65 | 1.31 | 1.27 | 0.72 | 0.72 | — |
Average Inventory |
— | 0.05 | — | — | — | — | 0.05 | 0.05 | — |
Average Assets |
9.44 | 12.58 | 20.22 | 30.17 | 20.96 | 5.21 | 4.13 | 2.02 | — |
Average Common Equity |
3.20 | 6.53 | 15.03 | 25.05 | 1.26 | (25.00) | (20.57) | (20.57) | — |
Columns are period end dates · fundamentals updated 26 Oct 2026